Your browser doesn't support javascript.
loading
Population pharmacokinetics of continuous-infusion ceftazidime in febrile neutropenic children undergoing HSCT: implications for target attainment for empirical treatment against Pseudomonas aeruginosa.
Cojutti, Pier Giorgio; Maximova, Natalia; Schillani, Giulia; Hope, William; Pea, Federico.
Affiliation
  • Cojutti PG; Institute of Clinical Pharmacology, Santa Maria della Misericordia University Hospital, ASUIUD, Udine, Italy.
  • Maximova N; Department of Medicine, University of Udine, Udine, Italy.
  • Schillani G; Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
  • Hope W; Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
  • Pea F; Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
J Antimicrob Chemother ; 74(6): 1648-1655, 2019 06 01.
Article in En | MEDLINE | ID: mdl-30838391

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pseudomonas aeruginosa / Pseudomonas Infections / Ceftazidime / Hematopoietic Stem Cell Transplantation / Febrile Neutropenia / Anti-Bacterial Agents Type of study: Health_economic_evaluation Limits: Child / Female / Humans / Male Language: En Journal: J Antimicrob Chemother Year: 2019 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pseudomonas aeruginosa / Pseudomonas Infections / Ceftazidime / Hematopoietic Stem Cell Transplantation / Febrile Neutropenia / Anti-Bacterial Agents Type of study: Health_economic_evaluation Limits: Child / Female / Humans / Male Language: En Journal: J Antimicrob Chemother Year: 2019 Type: Article Affiliation country: Italy